Literature DB >> 23782100

Haematological recovery in dyskeratosis congenita patients treated with danazol.

Amin Islam, Shafquat Rafiq, Mike Kirwan, Amanda Walne, Jamie Cavenagh, Tom Vulliamy, Inderjeet Dokal.   

Abstract

Entities:  

Keywords:  bone marrow failure; danazol; dyskeratosis congenita; telomerase; telomeres

Mesh：

Substances：

Year:  2013        PMID： 23782100     DOI： 10.1111/bjh.12432

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  18 in total

Review 1.  Alternative donor transplant of benign primary hematologic disorders.

Authors:  J Tolar; P Sodani; H Symons
Journal:  Bone Marrow Transplant       Date:  2015-02-09       Impact factor: 5.483

Review 2.  Nontransplant therapy for bone marrow failure.

Authors:  Danielle M Townsley; Thomas Winkler
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2016-12-02

3.  Response to androgen therapy in patients with dyskeratosis congenita.

Authors:  Payal P Khincha; Ingrid M Wentzensen; Neelam Giri; Blanche P Alter; Sharon A Savage
Journal:  Br J Haematol       Date:  2014-02-12       Impact factor: 6.998

Review 4.  Bone marrow failure and the telomeropathies.

Authors:  Danielle M Townsley; Bogdan Dumitriu; Neal S Young
Journal:  Blood       Date:  2014-09-18       Impact factor: 22.113

5.  Danazol Treatment for Telomere Diseases.

Authors:  Danielle M Townsley; Bogdan Dumitriu; Delong Liu; Angélique Biancotto; Barbara Weinstein; Christina Chen; Nathan Hardy; Andrew D Mihalek; Shilpa Lingala; Yun Ju Kim; Jianhua Yao; Elizabeth Jones; Bernadette R Gochuico; Theo Heller; Colin O Wu; Rodrigo T Calado; Phillip Scheinberg; Neal S Young
Journal:  N Engl J Med       Date:  2016-05-19       Impact factor: 91.245

6.  Colonic Angioectasia in an Adolescent Boy with Hoyeraal-Hreidarsson on Long-Term Anabolic Steroid Therapy.

Authors:  Racha Khalaf; Carmen Cuffari
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2018-01-12

Review 7.  Evaluation and Management of Hematopoietic Failure in Dyskeratosis Congenita.

Authors:  Suneet Agarwal
Journal:  Hematol Oncol Clin North Am       Date:  2018-05-28       Impact factor: 3.722

Review 8.  Genomic characterization of the inherited bone marrow failure syndromes.

Authors:  Payal P Khincha; Sharon A Savage
Journal:  Semin Hematol       Date:  2013-10       Impact factor: 3.851

9.  Brain imaging features of children with Hoyeraal-Hreidarsson syndrome.

Authors:  Ming-Jie Zhang; Ya-Xian Cao; Hui-Ying Wu; He-Hong Li
Journal:  Brain Behav       Date:  2021-03-18       Impact factor: 2.708

Review 10.  An update on the biology and management of dyskeratosis congenita and related telomere biology disorders.

Authors:  Marena R Niewisch; Sharon A Savage
Journal:  Expert Rev Hematol       Date:  2019-09-10       Impact factor: 2.819
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.